Deutsche Bank analyst Amit Mehrotra maintains CSX (NASDAQ:CSX) with a Buy and raises the price target from $36 to $39.
Deutsche Bank Maintains Buy on CSX, Raises Price Target to $39
Deutsche Bank analyst Amit Mehrotra maintains CSX (NASDAQ:CSX) with a Buy and raises the price target from $36 to $39.
Related Posts
Nanobiotix Announces Completion Of Phase 1 Dose Escalation And NBTXR3 Recommended Phase 2 Dose For The Treatment Of Inoperable, Recurrent Lung Cancer In Patients Amenable To Re-Irradiation
April 2, 4:17 PM
Established recommended Phase 2 dose of NBTXR3 for the treatment of patients with inoperable, recurrent non-small cell lung cancer ("NSCLC") who have previously received definitive radiation therapyConfirmation of
How Do Chipmakers Avoid The China Bans? Nvidia Might Have Something Up Its Sleeve
September 9, 1:37 PM
Mizuho analyst Vijay Rakesh reiterated a Buy and $225 price target on Nvidia Corp (NASDAQ:
AstraZeneca Expects FY23 Revenues To Increase By Low-To-Mid Single-Digit Percentage, With Core EPS To Increase By High Single-Digit To Low Double-Digit Percentage
February 9, 4:58 AM
Total Revenue excluding COVID-19 medicines is expected to increase by a low double-digit percentage